Phase I Clinical Trial of Recombinant Human Endostatin Administered as a Short Intravenous Infusion Repeated DailyJoseph P. Eder, Donald Küfe, Rocio García‐Carbonero et al.|Journal of Clinical Oncology|2002Cited by 244
Proteasome Inhibition With Bortezomib (PS-341): A Phase I Study With Pharmacodynamic End Points Using a Day 1 and Day 4 Schedule in a 14-Day CycleAnne Hamilton, Franco M. Muggia, Joseph P. Eder et al.|Journal of Clinical Oncology|2005Cited by 100